|
Exited Investments
Extract of the list of exited investments:
|
Apoxis S.A.
www.apoxis.com
Novo Nordisk Biotech Fund was a minority shareholder in Apoxis SA from December 2004 to June 2007 when the Danish biotech company TopoTarget A/S entered into an agreement to acquire Apoxis SA for EUR 14,5 million payable in TopoTarget shares. TopoTarget is listed on the Copenhagen Stock Exchange.
|
|
|
|
Domantis Limited
www.Domantis.com
Novo Nordisk Biotech Fund was a minority shareholder in Domantis Ltd from December 2005 to December 2006, when GlaxoSmithKline (GSK) entered into an agreement to acquire Domantis Ltd for GBP 230 million in cash.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
|
